Factors Associated With Readmissions Following Left Ventricular Assist Device Implantation

被引:0
|
作者
Eisenga, John B. [1 ,2 ,3 ]
Mccullough, Kyle A. [1 ,2 ]
Afzal, Aasim [1 ]
Dimaio, J. Michael [1 ,4 ]
Moubarak, Ghadi [1 ,2 ]
Milligan, Greg [1 ]
Kabra, Nitin [1 ]
Rusia, Akash [1 ]
Rawitscher, David A. [1 ]
George, Timothy J. [1 ]
机构
[1] Baylor Scott & White, Heart Hosp, Plano, TX USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
[3] Baylor Univ, Med Ctr, Dallas, TX USA
[4] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA
关键词
Heart failure; LVAD; NYHA; Outcomes; Readmission; HOSPITAL READMISSIONS; HEART-FAILURE; IMPACT;
D O I
10.1016/j.jss.2025.02.009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: While left ventricular device implantation has been shown to improve both survival and quality of life in patients with end stage heart failure, these patients have a high rate of readmissions to the hospital. The incidence and factors associated with readmission are poorly characterized in the destination therapy population. Methods: All patients who underwent HeartMate III left ventricular assist device therapy (LVAD) implantation at our facility from 2017 to 2023 were identified. Patients undergoing primary LVAD implantation were included. Primary outcome was readmission for any reason. Multivariable linear regression was utilized to identify predictors of readmissions. Results: From 2017 to 2023, 151 primary LVAD implantations were performed with 12 (8.0%) perioperative moralities (defined as index implant hospitalization mortality). The 139 remaining patients suffered 456 separate readmissions with a median follow-up of 590 (303-1002) ds and a total follow-up of 270.7 patient-ys for a rate of 1.7 readmissions per patient-y. The most common cause of readmission was heart failure exacerbation (27.0%), major infection (17.8%), and major bleeding (13.6%). Patients who were readmitted within 6 mos were more likely to have New York Heart Association class III or IV symptoms compared to those who had not been readmitted 39.1% versus 11.8% versus 15%, P = 0.0008. On multivariable linear regression, increasing body mass index (P = 0.02), increased preoperative bilirubin (P = 0.04), and increased follow-up time (P < 0.01) were predictive of the need for readmissions. Conclusions: Following LVAD implantation, readmissions within 6 mos of surgery are associated with worse functional status at 6 mos and 1 y postoperatively. Increased body mass index and preoperative bilirubin were associated with more frequent readmissions. (c) 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 50 条
  • [41] Psychiatric Disorders and Associated Factors in Left Ventricular Assist Device Implantation and Heart Transplant Candidates
    Ceran, Selvi
    Emekli, Esra
    Asut, Gonca
    Sezgin, Atilla
    CLINICAL TRANSPLANTATION, 2025, 39 (01)
  • [42] Trends and Outcomes of 30-day Readmissions After Left Ventricular Assist Device Implantation
    Ueyama, Hiroki
    Malik, Aaqib H.
    Kuno, Toshiki
    Yokoyama, Yujiro
    Briasoulis, Alexandros
    CIRCULATION, 2020, 142
  • [43] Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization
    Walther, Carl P.
    Winkelmayer, Wolfgang C.
    Deswal, Anita
    Niu, Jingbo
    Navaneethan, Sankar D.
    AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (03) : 172 - 181
  • [44] The analysis of unplanned readmissions after left ventricular assist device implantation as bridge-to-transplant
    Sezgin, Murat
    Rabus, Murat Bulent
    Selcuk, Emre
    Altas, Ozge
    Sankaya, Sabit
    Balkanay, Mehmet
    Kirali, Mehmet Kaan
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 28 (01): : 55 - 62
  • [45] Cardiovascular Implantable Electronic Device Surgery Following Left Ventricular Assist Device Implantation
    Black-Maier, Eric
    Lewis, Robert K.
    Loungani, Rahul
    Rehorn, Michael
    Friedman, Daniel J.
    Bishawi, Muath
    Schroder, Jacob N.
    Milano, Carmelo A.
    Katz, Jason N.
    Patel, Chetan B.
    Rogers, Joseph G.
    Hegland, Donald D.
    Jackson, Kevin P.
    Frazier-Mills, Camille
    Pokorney, Sean D.
    Daubert, James P.
    Piccini, Jonathan P.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2020, 6 (09) : 1131 - 1139
  • [46] Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis Following Left Ventricular Assist Device Implantation
    Bermudez, Francisca
    Rizk, Alexander a.
    Shah, Manish h.
    Sheikh, Farooq h.
    Oates, Connor p.
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (02) : 485 - 488
  • [47] How to Manage Ventricular Arrhythmia Following Durable Left Ventricular Assist Device Implantation
    Kataoka, Naoya
    Imamura, Teruhiko
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2025,
  • [48] Ventricular Arrhythmias in Patients Following Continuous Flow Left Ventricular Assist Device Implantation
    Garan, Arthur R.
    Morrison, Kery
    Letarte, Laure
    Vazquez, Jesus
    Dano, Drew
    Colombo, Paolo
    Yuzefnolskaya, Melana
    Te-Frey, Rosle
    Takayama, Hirno
    Naka, Yoshifumi
    Morrow, John
    Garan, Hasan
    Jorde, Ulrich P.
    Uriel, Nir
    CIRCULATION, 2012, 126 (21)
  • [49] Treatment of Ventricular Assist Device Thrombus by Implantation of an Additional Left Ventricular Assist Device
    Ricklefs, Marcel
    Hanke, Jasmin S.
    Schmitto, Jan D.
    ARTIFICIAL ORGANS, 2018, 42 (04) : 464 - 465
  • [50] How to Manage Ventricular Arrhythmia Following Durable Left Ventricular Assist Device Implantation
    Efimova, Elena
    Arya, Arash
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2025, 36 (03) : 721 - 722